Protective effects of shark hepatic stimulator substance against acute hepatic injury induced by acetaminophen in mice

Yaoxue Xuebao

Volumn 39, Issue 1, 2004, Pages 17-21

  Lü, Zheng Bing ^a   Li, Qian ^a   Ye, Bo Ping ^a   Bian, Shan ^a   Wang, Ying ^a   Ruan, Qi Ping ^a   Wu, Wu Tong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Acetaminophen; Fas; Shark hepatic stimulator substance

Indexed keywords

FAS ANTIGEN; LIVER ENZYME; PARACETAMOL; GROWTH PROMOTOR; HEPATIC STIMULATOR SUBSTANCE; MESSENGER RNA; PEPTIDE; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME ASSAY; FLOW CYTOMETRY; INFLAMMATION; LIVER CELL; LIVER INJURY; MICROSCOPY; MOUSE; MOUSE STRAIN; NECROSIS; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DRUG EFFECT; FEMALE; GENETICS; ISOLATION AND PURIFICATION; PATHOLOGY; RANDOMIZATION; SHARK; TOXIC HEPATITIS;

ACETAMINOPHEN; ANIMALS; ANTIGENS, CD95; APOPTOSIS; FEMALE; GROWTH SUBSTANCES; HEPATITIS, TOXIC; MICE; MICE, INBRED BALB C; PEPTIDES; PROTECTIVE AGENTS; RANDOM ALLOCATION; RNA, MESSENGER; SHARKS;

EID: 3242760751     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Xu SY, Bian RN, Chen X. Experimental Methods in Pharmacology. 3 rd Ed. Beijing: People's Hygiene Publishing House, 2002.1346.
2. Ray SD, Mumaw VR, Raje RR, et al. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment [J]. Pharmacol Exp Ther, 1996,279(3):1470-1483.
3. Guo Y, Wu WT, Wu GZ. The liver-protective and immunomodulative effect of Shahepatic in mice with immune liver injury [J]. Chin J New Drugs, 2001,10(1):29-32.
4. Guo Y, Sheng Q, Wu WT. Protective effect of CPU-HAP-140 against acute liver failure in mice [J]. Pharm Biotechnol, 2000,7(2):82-86.
5. Guo Y, Wu WT. Purification and physicochemical characteristics of shark hepatic stimulator substance [J]. J Chin Pharm Sci, 2001,10(2):7.
6. Pong LM, Wang ZL. Basic and Clinic Study of Apoptosis. Beijing: People's Hygiene Publishing House, 2000.171.
7. Nayersina R, Fowler P, Guilhot S, et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection [J]. J Immunol, 1993,150(10):4659-4671.
8. Zhang H, Cook J, Nickel J, et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminat hepatitis [J]. Nature Biotechnol, 2000,118(8):862 -867.
9. Ryo K, amogawa Y, Ikeda I, et al. Fas and Fas ligand strongly expressed in liver of fulminant hepatisis patients [J]. Hepatology, 1995,22(4):230a.
10. Watanabe-fukunaga R, Brannan CI, Iton N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen [J]. J Immunol, 1992,148(4):1274 -1279.